Global Metabotropic Glutamate Receptor (MRG) Market Growth 2025-2031

October 2025 | 82 pages | ID: G08911D42A49EN
LP Information

Abstracts

The global Metabotropic Glutamate Receptor (MRG) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

The metabotropic glutamate receptors are a type of glutamate receptor that are active through an indirect metabotropic process.

United States market for Metabotropic Glutamate Receptor (MRG) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Metabotropic Glutamate Receptor (MRG) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Metabotropic Glutamate Receptor (MRG) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Metabotropic Glutamate Receptor (MRG) players cover Addex Therapeutics, Domain Therapeutics, Medgenics, Prexton Therapeutics, Taisho Pharmaceutical Holding, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Metabotropic Glutamate Receptor (MRG) Industry Forecast” looks at past sales and reviews total world Metabotropic Glutamate Receptor (MRG) sales in 2024, providing a comprehensive analysis by region and market sector of projected Metabotropic Glutamate Receptor (MRG) sales for 2025 through 2031. With Metabotropic Glutamate Receptor (MRG) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metabotropic Glutamate Receptor (MRG) industry.

This Insight Report provides a comprehensive analysis of the global Metabotropic Glutamate Receptor (MRG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metabotropic Glutamate Receptor (MRG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metabotropic Glutamate Receptor (MRG) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metabotropic Glutamate Receptor (MRG) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metabotropic Glutamate Receptor (MRG).

This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor (MRG) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• mGluR2
• mGluR4
• mGluR5

Segmentation by Application:

• Meningitis
• Septicemia
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Addex Therapeutics
• Domain Therapeutics
• Medgenics
• Prexton Therapeutics
• Taisho Pharmaceutical Holding

Key Questions Addressed in this Report

What is the 10-year outlook for the global Metabotropic Glutamate Receptor (MRG) market?
What factors are driving Metabotropic Glutamate Receptor (MRG) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metabotropic Glutamate Receptor (MRG) market opportunities vary by end market size?
How does Metabotropic Glutamate Receptor (MRG) break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Metabotropic Glutamate Receptor (MRG) Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor (MRG) by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor (MRG) by Country/Region, 2020, 2024 & 2031
2.2 Metabotropic Glutamate Receptor (MRG) Segment by Type
  2.2.1 mGluR2
  2.2.2 mGluR4
  2.2.3 mGluR5
2.3 Metabotropic Glutamate Receptor (MRG) Sales by Type
  2.3.1 Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Type (2020-2025)
  2.3.2 Global Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Metabotropic Glutamate Receptor (MRG) Sale Price by Type (2020-2025)
2.4 Metabotropic Glutamate Receptor (MRG) Segment by Application
  2.4.1 Meningitis
  2.4.2 Septicemia
  2.4.3 Others
2.5 Metabotropic Glutamate Receptor (MRG) Sales by Application
  2.5.1 Global Metabotropic Glutamate Receptor (MRG) Sale Market Share by Application (2020-2025)
  2.5.2 Global Metabotropic Glutamate Receptor (MRG) Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Metabotropic Glutamate Receptor (MRG) Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Metabotropic Glutamate Receptor (MRG) Breakdown Data by Company
  3.1.1 Global Metabotropic Glutamate Receptor (MRG) Annual Sales by Company (2020-2025)
  3.1.2 Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Company (2020-2025)
3.2 Global Metabotropic Glutamate Receptor (MRG) Annual Revenue by Company (2020-2025)
  3.2.1 Global Metabotropic Glutamate Receptor (MRG) Revenue by Company (2020-2025)
  3.2.2 Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Company (2020-2025)
3.3 Global Metabotropic Glutamate Receptor (MRG) Sale Price by Company
3.4 Key Manufacturers Metabotropic Glutamate Receptor (MRG) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Metabotropic Glutamate Receptor (MRG) Product Location Distribution
  3.4.2 Players Metabotropic Glutamate Receptor (MRG) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR (MRG) BY GEOGRAPHIC REGION

4.1 World Historic Metabotropic Glutamate Receptor (MRG) Market Size by Geographic Region (2020-2025)
  4.1.1 Global Metabotropic Glutamate Receptor (MRG) Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Metabotropic Glutamate Receptor (MRG) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Metabotropic Glutamate Receptor (MRG) Market Size by Country/Region (2020-2025)
  4.2.1 Global Metabotropic Glutamate Receptor (MRG) Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Metabotropic Glutamate Receptor (MRG) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Metabotropic Glutamate Receptor (MRG) Sales Growth
4.4 APAC Metabotropic Glutamate Receptor (MRG) Sales Growth
4.5 Europe Metabotropic Glutamate Receptor (MRG) Sales Growth
4.6 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Growth

5 AMERICAS

5.1 Americas Metabotropic Glutamate Receptor (MRG) Sales by Country
  5.1.1 Americas Metabotropic Glutamate Receptor (MRG) Sales by Country (2020-2025)
  5.1.2 Americas Metabotropic Glutamate Receptor (MRG) Revenue by Country (2020-2025)
5.2 Americas Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025)
5.3 Americas Metabotropic Glutamate Receptor (MRG) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Metabotropic Glutamate Receptor (MRG) Sales by Region
  6.1.1 APAC Metabotropic Glutamate Receptor (MRG) Sales by Region (2020-2025)
  6.1.2 APAC Metabotropic Glutamate Receptor (MRG) Revenue by Region (2020-2025)
6.2 APAC Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025)
6.3 APAC Metabotropic Glutamate Receptor (MRG) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Metabotropic Glutamate Receptor (MRG) by Country
  7.1.1 Europe Metabotropic Glutamate Receptor (MRG) Sales by Country (2020-2025)
  7.1.2 Europe Metabotropic Glutamate Receptor (MRG) Revenue by Country (2020-2025)
7.2 Europe Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025)
7.3 Europe Metabotropic Glutamate Receptor (MRG) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Metabotropic Glutamate Receptor (MRG) by Country
  8.1.1 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Revenue by Country (2020-2025)
8.2 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025)
8.3 Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor (MRG)
10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor (MRG)
10.4 Industry Chain Structure of Metabotropic Glutamate Receptor (MRG)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Metabotropic Glutamate Receptor (MRG) Distributors
11.3 Metabotropic Glutamate Receptor (MRG) Customer

12 WORLD FORECAST REVIEW FOR METABOTROPIC GLUTAMATE RECEPTOR (MRG) BY GEOGRAPHIC REGION

12.1 Global Metabotropic Glutamate Receptor (MRG) Market Size Forecast by Region
  12.1.1 Global Metabotropic Glutamate Receptor (MRG) Forecast by Region (2026-2031)
  12.1.2 Global Metabotropic Glutamate Receptor (MRG) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Metabotropic Glutamate Receptor (MRG) Forecast by Type (2026-2031)
12.7 Global Metabotropic Glutamate Receptor (MRG) Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Addex Therapeutics
  13.1.1 Addex Therapeutics Company Information
  13.1.2 Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
  13.1.3 Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Addex Therapeutics Main Business Overview
  13.1.5 Addex Therapeutics Latest Developments
13.2 Domain Therapeutics
  13.2.1 Domain Therapeutics Company Information
  13.2.2 Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
  13.2.3 Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Domain Therapeutics Main Business Overview
  13.2.5 Domain Therapeutics Latest Developments
13.3 Medgenics
  13.3.1 Medgenics Company Information
  13.3.2 Medgenics Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
  13.3.3 Medgenics Metabotropic Glutamate Receptor (MRG) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Medgenics Main Business Overview
  13.3.5 Medgenics Latest Developments
13.4 Prexton Therapeutics
  13.4.1 Prexton Therapeutics Company Information
  13.4.2 Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
  13.4.3 Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Prexton Therapeutics Main Business Overview
  13.4.5 Prexton Therapeutics Latest Developments
13.5 Taisho Pharmaceutical Holding
  13.5.1 Taisho Pharmaceutical Holding Company Information
  13.5.2 Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
  13.5.3 Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Taisho Pharmaceutical Holding Main Business Overview
  13.5.5 Taisho Pharmaceutical Holding Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Metabotropic Glutamate Receptor (MRG) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Metabotropic Glutamate Receptor (MRG) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of mGluR2
Table 4. Major Players of mGluR4
Table 5. Major Players of mGluR5
Table 6. Global Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025) & (K Units)
Table 7. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Type (2020-2025)
Table 8. Global Metabotropic Glutamate Receptor (MRG) Revenue by Type (2020-2025) & ($ million)
Table 9. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Type (2020-2025)
Table 10. Global Metabotropic Glutamate Receptor (MRG) Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Metabotropic Glutamate Receptor (MRG) Sale by Application (2020-2025) & (K Units)
Table 12. Global Metabotropic Glutamate Receptor (MRG) Sale Market Share by Application (2020-2025)
Table 13. Global Metabotropic Glutamate Receptor (MRG) Revenue by Application (2020-2025) & ($ million)
Table 14. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Application (2020-2025)
Table 15. Global Metabotropic Glutamate Receptor (MRG) Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Metabotropic Glutamate Receptor (MRG) Sales by Company (2020-2025) & (K Units)
Table 17. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Company (2020-2025)
Table 18. Global Metabotropic Glutamate Receptor (MRG) Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Company (2020-2025)
Table 20. Global Metabotropic Glutamate Receptor (MRG) Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Metabotropic Glutamate Receptor (MRG) Producing Area Distribution and Sales Area
Table 22. Players Metabotropic Glutamate Receptor (MRG) Products Offered
Table 23. Metabotropic Glutamate Receptor (MRG) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Metabotropic Glutamate Receptor (MRG) Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share Geographic Region (2020-2025)
Table 28. Global Metabotropic Glutamate Receptor (MRG) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Metabotropic Glutamate Receptor (MRG) Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country/Region (2020-2025)
Table 32. Global Metabotropic Glutamate Receptor (MRG) Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Metabotropic Glutamate Receptor (MRG) Sales by Country (2020-2025) & (K Units)
Table 35. Americas Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country (2020-2025)
Table 36. Americas Metabotropic Glutamate Receptor (MRG) Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025) & (K Units)
Table 38. Americas Metabotropic Glutamate Receptor (MRG) Sales by Application (2020-2025) & (K Units)
Table 39. APAC Metabotropic Glutamate Receptor (MRG) Sales by Region (2020-2025) & (K Units)
Table 40. APAC Metabotropic Glutamate Receptor (MRG) Sales Market Share by Region (2020-2025)
Table 41. APAC Metabotropic Glutamate Receptor (MRG) Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025) & (K Units)
Table 43. APAC Metabotropic Glutamate Receptor (MRG) Sales by Application (2020-2025) & (K Units)
Table 44. Europe Metabotropic Glutamate Receptor (MRG) Sales by Country (2020-2025) & (K Units)
Table 45. Europe Metabotropic Glutamate Receptor (MRG) Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025) & (K Units)
Table 47. Europe Metabotropic Glutamate Receptor (MRG) Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor (MRG)
Table 53. Key Market Challenges & Risks of Metabotropic Glutamate Receptor (MRG)
Table 54. Key Industry Trends of Metabotropic Glutamate Receptor (MRG)
Table 55. Metabotropic Glutamate Receptor (MRG) Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Metabotropic Glutamate Receptor (MRG) Distributors List
Table 58. Metabotropic Glutamate Receptor (MRG) Customer List
Table 59. Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Metabotropic Glutamate Receptor (MRG) Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Metabotropic Glutamate Receptor (MRG) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Metabotropic Glutamate Receptor (MRG) Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Metabotropic Glutamate Receptor (MRG) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Metabotropic Glutamate Receptor (MRG) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Metabotropic Glutamate Receptor (MRG) Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Metabotropic Glutamate Receptor (MRG) Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Metabotropic Glutamate Receptor (MRG) Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Addex Therapeutics Basic Information, Metabotropic Glutamate Receptor (MRG) Manufacturing Base, Sales Area and Its Competitors
Table 74. Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
Table 75. Addex Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Addex Therapeutics Main Business
Table 77. Addex Therapeutics Latest Developments
Table 78. Domain Therapeutics Basic Information, Metabotropic Glutamate Receptor (MRG) Manufacturing Base, Sales Area and Its Competitors
Table 79. Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
Table 80. Domain Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Domain Therapeutics Main Business
Table 82. Domain Therapeutics Latest Developments
Table 83. Medgenics Basic Information, Metabotropic Glutamate Receptor (MRG) Manufacturing Base, Sales Area and Its Competitors
Table 84. Medgenics Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
Table 85. Medgenics Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Medgenics Main Business
Table 87. Medgenics Latest Developments
Table 88. Prexton Therapeutics Basic Information, Metabotropic Glutamate Receptor (MRG) Manufacturing Base, Sales Area and Its Competitors
Table 89. Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
Table 90. Prexton Therapeutics Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Prexton Therapeutics Main Business
Table 92. Prexton Therapeutics Latest Developments
Table 93. Taisho Pharmaceutical Holding Basic Information, Metabotropic Glutamate Receptor (MRG) Manufacturing Base, Sales Area and Its Competitors
Table 94. Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Product Portfolios and Specifications
Table 95. Taisho Pharmaceutical Holding Metabotropic Glutamate Receptor (MRG) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Taisho Pharmaceutical Holding Main Business
Table 97. Taisho Pharmaceutical Holding Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Metabotropic Glutamate Receptor (MRG)
Figure 2. Metabotropic Glutamate Receptor (MRG) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metabotropic Glutamate Receptor (MRG) Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Metabotropic Glutamate Receptor (MRG) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Metabotropic Glutamate Receptor (MRG) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country/Region (2024)
Figure 10. Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of mGluR2
Figure 12. Product Picture of mGluR4
Figure 13. Product Picture of mGluR5
Figure 14. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Type in 2025
Figure 15. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Type (2020-2025)
Figure 16. Metabotropic Glutamate Receptor (MRG) Consumed in Meningitis
Figure 17. Global Metabotropic Glutamate Receptor (MRG) Market: Meningitis (2020-2025) & (K Units)
Figure 18. Metabotropic Glutamate Receptor (MRG) Consumed in Septicemia
Figure 19. Global Metabotropic Glutamate Receptor (MRG) Market: Septicemia (2020-2025) & (K Units)
Figure 20. Metabotropic Glutamate Receptor (MRG) Consumed in Others
Figure 21. Global Metabotropic Glutamate Receptor (MRG) Market: Others (2020-2025) & (K Units)
Figure 22. Global Metabotropic Glutamate Receptor (MRG) Sale Market Share by Application (2024)
Figure 23. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Application in 2025
Figure 24. Metabotropic Glutamate Receptor (MRG) Sales by Company in 2025 (K Units)
Figure 25. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Company in 2025
Figure 26. Metabotropic Glutamate Receptor (MRG) Revenue by Company in 2025 ($ millions)
Figure 27. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Company in 2025
Figure 28. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Metabotropic Glutamate Receptor (MRG) Sales 2020-2025 (K Units)
Figure 31. Americas Metabotropic Glutamate Receptor (MRG) Revenue 2020-2025 ($ millions)
Figure 32. APAC Metabotropic Glutamate Receptor (MRG) Sales 2020-2025 (K Units)
Figure 33. APAC Metabotropic Glutamate Receptor (MRG) Revenue 2020-2025 ($ millions)
Figure 34. Europe Metabotropic Glutamate Receptor (MRG) Sales 2020-2025 (K Units)
Figure 35. Europe Metabotropic Glutamate Receptor (MRG) Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Revenue 2020-2025 ($ millions)
Figure 38. Americas Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country in 2025
Figure 39. Americas Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Country (2020-2025)
Figure 40. Americas Metabotropic Glutamate Receptor (MRG) Sales Market Share by Type (2020-2025)
Figure 41. Americas Metabotropic Glutamate Receptor (MRG) Sales Market Share by Application (2020-2025)
Figure 42. United States Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Metabotropic Glutamate Receptor (MRG) Sales Market Share by Region in 2025
Figure 47. APAC Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Region (2020-2025)
Figure 48. APAC Metabotropic Glutamate Receptor (MRG) Sales Market Share by Type (2020-2025)
Figure 49. APAC Metabotropic Glutamate Receptor (MRG) Sales Market Share by Application (2020-2025)
Figure 50. China Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 54. India Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country in 2025
Figure 58. Europe Metabotropic Glutamate Receptor (MRG) Revenue Market Share by Country (2020-2025)
Figure 59. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share by Type (2020-2025)
Figure 60. Europe Metabotropic Glutamate Receptor (MRG) Sales Market Share by Application (2020-2025)
Figure 61. Germany Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 62. France Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Metabotropic Glutamate Receptor (MRG) Sales Market Share by Application (2020-2025)
Figure 69. Egypt Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Metabotropic Glutamate Receptor (MRG) Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor (MRG) in 2025
Figure 75. Manufacturing Process Analysis of Metabotropic Glutamate Receptor (MRG)
Figure 76. Industry Chain Structure of Metabotropic Glutamate Receptor (MRG)
Figure 77. Channels of Distribution
Figure 78. Global Metabotropic Glutamate Receptor (MRG) Sales Market Forecast by Region (2026-2031)
Figure 79. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Metabotropic Glutamate Receptor (MRG) Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Metabotropic Glutamate Receptor (MRG) Revenue Market Share Forecast by Application (2026-2031)